Drug or technology

Finerenone

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 3 TRIAL

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

ClinicalTrials.gov

This is a Phase 3 trial registry record with no posted results; the study is actively recruiting and efficacy and safety outcomes have not yet been reported.

PreliminaryFinerenone NCT06024746 Heart Failure

Reported

Planned enrollment1500

Study phasePHASE 3

Primary outcome measure 1Clinical benefit at 6 months

AUG 10, 2026 · PHASE 2 TRIAL

Precision T1D Platform - New Therapies for Cardio-Renal Complications

ClinicalTrials.gov

A Phase 2 interventional trial registered but not yet recruiting, with safety and tolerability as primary outcomes in a small planned cohort; no results are posted.

PreliminaryCardio Renal Vascular Function and Failure T1D Heart Failure NCT07594145

Reported

Planned sample size57

Study phasePhase 2

Primary outcome measure 1Markers of Renal Health [Safety and Tolerab…